Review
Linzagolix reduces endometriosis-associated pain, but long-term safety remains uncertain
Consider linzagolix when other hormonal therapy fails, causes unacceptable adverse effects or is contraindicated. The review recommends monitoring bone mineral density and performing DXA after one year.
#linzagolix ge-bu.nl